Lyell Immunopharma (LYEL) Other Working Capital Changes (2021 - 2026)
Lyell Immunopharma (LYEL) posted Other Working Capital Changes of $10000.0 for Q1 2026, up 100.46% sequentially from -$2.2 million in Q4 2025, and up 108.93% YoY from $4786.3 in Q1 2025.
Lyell Immunopharma (LYEL) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Lyell Immunopharma has reported Other Working Capital Changes for 6 years, with the latest figure at $10000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 108.93% year-over-year to $10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 537.56% YoY) and the FY2025 annual result came in at -$2.7 million, down 565.69% from the prior year.
- Other Working Capital Changes climbed to $10000.0 in Q1 2026 per LYEL's latest filing, from -$2.2 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.4 million in Q4 2025 and troughed at -$3.6 million in Q4 2024.
- A 5-year average of -$343823.5 and a median of -$90000.0 in 2026 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes jumped 234.73% in 2022, then plunged 593.59% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$3.8 million in 2022, then jumped by 97.04% to -$112000.0 in 2023, then plunged by 178.57% to -$312000.0 in 2024, then slumped by 593.59% to -$2.2 million in 2025, then jumped by 100.46% to $10000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $10000.0, -$2.2 million, and -$349000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lyell Immunopharma | 326.39 Mn | 326.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Jun 30, 2026 | 10,000.00 |
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | -2.16 Mn |
| Dec 31, 2025 | -2.16 Mn |
| Dec 31, 2025 | -2.16 Mn |
| Sep 30, 2025 | -349,000.00 |
| Sep 30, 2025 | -349,000.00 |
| Sep 30, 2025 | -349,000.00 |
| Jun 30, 2025 | -111,000.00 |
| Jun 30, 2025 | -111,000.00 |
| Jun 30, 2025 | -111,000.00 |
| Mar 31, 2025 | -112,000.00 |
| Mar 31, 2025 | -112,000.00 |
| Mar 31, 2025 | -112,000.00 |
| Dec 31, 2024 | -312,000.00 |
| Dec 31, 2024 | -312,000.00 |